Effectiveness of Care in Certified Cancer Centres in Germany
NCT ID: NCT04334239
Last Updated: 2022-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
670000 participants
OBSERVATIONAL
2017-05-01
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery
NCT01278537
Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany
NCT05319925
E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research
NCT03132506
A Multi-center Investigation of Family Health.
NCT06433349
Evaluation of Needs of Patients and Care-givers During and After Radiotherapy of Patients With Prostate Cancer
NCT07156903
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The project "Wirksamkeit der Versorgung in onkologischen Zentren" (WiZen) investigates effects of treatments in certified cancer centres across large populations and different cancer entities in comparison to hospitals that do not hold a certificate.
WiZen is a retrospective comparative cohort study that analyzes incident cases of eight types of cancer diagnosed within 2009-2017 based on nationwide health insurance data provided by WIdO (the AOK research institute) and data from regional clinical cancer registries (CCR) for the period 2006-2017. These eight types of cancer are colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors and neuro-oncological tumors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Cancer patients who have undergone substantial parts of inpatient treatment in a certified cancer centre.
Oncological certification
Oncological certification encompasses a variety of criteria such as treatment according to the clinical guidelines, staffing, technical infrastructure, minimum caseloads, and multidisciplinary care.
Control
Cancer patients who have not undergone inpatient treatment in a certified cancer centre.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oncological certification
Oncological certification encompasses a variety of criteria such as treatment according to the clinical guidelines, staffing, technical infrastructure, minimum caseloads, and multidisciplinary care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalization due to primary diagnosis of colorectal cancer, pancreatic cancer, breast cancer, gynecologic tumors, lung cancer, prostate cancer, head and neck tumors, or neuro-oncological tumors 2006-2017 \[CCR\]
Exclusion Criteria
* exception: outpatient cancer diagnosis up to 12 months prior to first hospitalization is not regarded as prevalent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Tumorzentrum Regensburg, Institut für Qualitätssicherung und Versorgungsforschung, Universität Regensburg
UNKNOWN
Arbeitsgemeinschaft Deutscher Tumorzenten e.V., ADT
UNKNOWN
Wissenschaftliches Institut der AOK (WIdO)
UNKNOWN
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jochen Schmitt.
Prof. Dr. med. Jochen Schmitt, MPH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Technische Universität Dresden
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Roessler M, Schmitt J, Bobeth C, Gerken M, Kleihues-van Tol K, Reissfelder C, Rau BM, Distler M, Piso P, Gunster C, Klinkhammer-Schalke M, Schoffer O, Bierbaum V. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer. 2022 Jun 7;22(1):621. doi: 10.1186/s12885-022-09731-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01VSF17020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.